Recombinant activated factor VII for treatment of enoxaparin-induced bleeding [1]

Mayo Clinic Proceedings

Volumn 79, Issue 6, 2004, Pages 827-

  Hu, Qiyue ^a   Brady, James O ^a  

^a GEISINGER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ABDOMINAL BLEEDING; AGED; BLEEDING; BOLUS INJECTION; CASE REPORT; HEMOSTASIS; HUMAN; LETTER; MALE; RECTUS ABDOMINIS MUSCLE; SURGICAL APPROACH;

EID: 2542449971     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/79.6.827     Document Type: Letter

References (7)

1. Antman EM, Cohen M, Radley D, et al. Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction: TIMI IIB-ESSENCE meta-analysis. Circulation. 1999;100:1602-1608.
2. Olson S, Rossato R, Guazzo E. Acute subdural haematomas and enoxaparin. J Clin Neurosci. 2002;9:256-259.
3. Gerotziafas GT, Samama MM. On the mechanism of inhibition of factor VIIa by synthetic pentasaccharide, low molecular-weight heparins and unfractionated heparin [letter]. Br J Haematol. 2000;109:903-905.
4. Bjorquist P, Bostrom S. Determination of the kinetic constants of tissue factor/factor VII/factor VIIA and antithrombin/heparin using surface plasmon resonance. Thromb Res. 1997;85:225-236.
5. Hoffman R, Mahajana A, Agmon P, Baruch Y, Brenner B. Successful use of recombinant activated factor VII (Novoseven) in controlling severe intra-abdominal bleeding after liver needle biopsy [letter]. Thromb Haemost. 2002;87:346-347.
6. Ng HJ, Koh LP, Lee LH. Successful control of postsurgical bleeding by recombinant factor VIIa in a renal failure patient given low molecular weight heparin and aspirin. Ann Hematol. 2003;82:257-258.
7. Chan S, Kong M, Minning DM, Hedner U, Marder VJ. Assessment of recombinant factor VIIa as an antidote for bleeding induced in the rabbit by low molecular weight heparin. J Thromb Haemost. 2003;1:760-765.